Literature DB >> 12488539

The effect of insulin on expression level of nucleoside transporters in diabetic rats.

Tadeusz Pawelczyk1, Marzena Podgorska, Monika Sakowicz.   

Abstract

Evidence that the time course of insulin-induced changes in adenosine level in diabetic rats is different from that observed for expression of adenosine kinase prompted us to study the insulin effect on expression of nucleoside transporters in tissues of diabetic rats. RNase protection assay demonstrated that mRNA levels of equilibrative (rENT) and Na+-dependent nucleoside transporters (rCNT) were altered in diabetic tissues. The rENT1 mRNA level with respect to values obtained in age- and sex-matched nondiabetic rats was decreased by 45, 32, and 10% in diabetic heart, liver, and kidney, respectively. The level of rENT2 mRNA was lowered by 40% in diabetic kidney and heart, and by 24% in diabetic liver. Changes in the expression pattern of rCNT1 and rCNT2 in diabetic tissues differed significantly from that observed for rENT. The levels of rCNT1 and rCNT2 mRNA did not change significantly in diabetic kidney. In diabetic heart, the mRNA levels of rCNT1 and rCNT2 increased 1.7- and 2-fold, respectively. Changes in expression of nucleoside transporters were accompanied by alterations in adenosine content. Administration of insulin to diabetic rats resulted in a drop in adenosine concentration in examined tissues and return of the rCNT1, rCNT2, and rENT2 but not rENT1 mRNA levels to values observed in nondiabetic rats. In summary, these data demonstrate that insulin affects expression of nucleoside transporters in a cell-specific manner. We conclude that change in the expression level of the nucleoside transporters occurring in tissues of diabetic rat is an important factor influencing adenosine levels in the cell.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12488539     DOI: 10.1124/mol.63.1.81

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat.

Authors:  Tadeusz Pawelczyk; Marzena Grden; Robert Rzepko; Monika Sakowicz; Andrzej Szutowicz
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 2.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

3.  Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes.

Authors:  Monika Sakowicz-Burkiewicz; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

4.  Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology.

Authors:  Shuyuan Chen; Jia-huan Ding; Raffi Bekeredjian; Bing-zhi Yang; Ralph V Shohet; Stephen A Johnston; Hans E Hohmeier; Christopher B Newgard; Paul A Grayburn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-18       Impact factor: 11.205

5.  Role of adenosine in diabetic retinopathy.

Authors:  Gregory I Liou; Saif Ahmad; Mohammad Naime; Nadeem Fatteh; Ahmed S Ibrahim
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-11

Review 6.  Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?

Authors:  Cui Yang; George P H Leung
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

7.  Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus.

Authors:  Bagher Larijani; Ramin Heshmat; Mina Ebrahimi-Rad; Shohreh Khatami; Shirin Valadbeigi; Reza Saghiri
Journal:  Enzyme Res       Date:  2016-12-05

8.  Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.

Authors:  Sebastián Alarcón; Wallys Garrido; Génesis Vega; Claudio Cappelli; Raibel Suárez; Carlos Oyarzún; Claudia Quezada; Rody San Martín
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

9.  Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.

Authors:  Catalina Kretschmar; Carlos Oyarzún; Cristopher Villablanca; Catherinne Jaramillo; Sebastián Alarcón; Gustavo Perez; Montserrat M Díaz-Encarnación; Marçal Pastor-Anglada; Wallys Garrido; Claudia Quezada; Rody San Martín
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction.

Authors:  M Verónica Donoso; M Jesús Mascayano; Inés M Poblete; J Pablo Huidobro-Toro
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.